10-K · February 26, 2026
The Pennant Group, Inc. reported a strong fiscal year 2025 with a 36.3% increase in revenue, reaching $947.7 million, largely driven by acquisitions and organic growth across its home health and hospice services. The…
Earnings analysis · 10-Q
Filed May 6, 2026 · Our reading of the company's report
The latest report
The Pennant Group, Inc. reported Q1 2026 results with a total revenue of $285.4 million, surpassing estimates of $280.9 million, but with an EPS of $0.24, falling short of the anticipated $0.29. Despite this earnings…
The Pennant Group, Inc. reported Q1 2026 results with a total revenue of $285.4 million, surpassing estimates of $280.9 million, but with an EPS of $0.24, falling short of the anticipated $0.29. Despite this earnings miss, the company remains optimistic about growth led by robust performances in home health services and effective acquisition integration.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
The company reported revenue of $285.4 million, exceeding the estimated $280.9 million for Q1 2026.
Reported EPS came in at $0.24, below the expected $0.29 for the quarter.
Management highlighted strong performance in home health services as a key growth driver.
Q1 2026 revenue showed significant strength compared to $229 million in Q1 2025, reflecting a 24.6% year-over-year growth.
Management noted improvements in integrating acquisitions, contributing to operational efficiencies.
Gross margin for the quarter stood at 19.8%, slightly lower than the prior quarter's 19.9%.
The company remains exposed to regulatory changes affecting reimbursement, which could impact profitability.
Management flagged ongoing integration challenges that could disrupt operational efficiencies in future quarters.
An additional risk factor has been noted regarding the regulation of artificial intelligence, which may increase compliance costs.
No specific numeric guidance was provided; management expressed confidence in growth prospects.
The Pennant Group, Inc. reported a strong fiscal year 2025 with a 36.3% increase in revenue, reaching $947.7 million, largely driven by acquisitions and organic growth across its home health and hospice services. The…
The Pennant Group reported strong Q3 2025 results, with revenues rising 26.8% to $229 million and EPS beating estimates at $0.30 vs. $0.26 expected. Despite this strong performance, the company faces headwinds from…
The Pennant Group, Inc. reported strong financial results for Q2 2025, with revenues increasing by 30.1% year-over-year to $219.5 million, and EPS rising to $0.27, effectively beating analyst estimates. The company…
For Q1 2025, Pennant Group reported robust financial performance, generating revenues of $209.8 million, up 33.7% year-over-year, and an EPS of $0.27, exceeding estimates. Despite a notable revenue increase driven by…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.